[Retracted] Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling

Following the publication of the above paper, it was drawn to the Editor’s attention by a concerned reader that certain of the western blot data featured in Fig. 2A on p. 533 were strikingly similar to data that had already been submitted for publication to the journal OncoTargets and Therapy in a paper that was written by different authors at different research insititutes. Additionally, data from the same figure were found to be remarkably similar to western blot data that were submitted to other journals in papers written by different authors either at around the same time, or up to a couple of years afterwards. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 20: 529‑538, 2019; DOI: 10.3892/mmr.2019.10285]

Authors

Institutions

Publication Details

Journal
Molecular Medicine Reports
Published
2026-11-16
DOI
https://doi.org/10.3892/mmr.2026.14072
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

[Retracted] Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling

Chi Gu, Guofu Wang, Jirong Wang, Jing Yan et al.
Molecular Medicine Reports
Parkinson's Disease Mechanisms and Treatments
article

[Retracted] Salidroside protects SH‑SY5Y from pathogenic α‑synuclein by promoting cell autophagy via mediation of mTOR/p70S6K signaling

Chi Gu, Guofu Wang, Jirong Wang, Jing Yan, Feng Cai, Genxiang Mao, Zhouxin Yang, Shasha Chen
article en

Abstract

Following the publication of the above paper, it was drawn to the Editor’s attention by a concerned reader that certain of the western blot data featured in Fig. 2A on p. 533 were strikingly similar to data that had already been submitted for publication to the journal OncoTargets and Therapy in a paper that was written by different authors at different research insititutes. Additionally, data from the same figure were found to be remarkably similar to western blot data that were submitted to other journals in papers written by different authors either at around the same time, or up to a couple of years afterwards. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 20: 529‑538, 2019; DOI: 10.3892/mmr.2019.10285]

Molecular Medicine ReportsVol. 35(1)
Zhejiang Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Zhejiang University (CN)
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon